Richard P Buyalos
Overview
Explore the profile of Richard P Buyalos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
69
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hatoum S, Amiri M, Hopkins D, Buyalos R, Bril F, Azziz R
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39833660
Background: Polycystic ovary syndrome (PCOS) is one of the most prevalent cardio-metabolic disorders in women. However, PCOS diagnosis is often missed or delayed, which may have serious physical and mental...
2.
Amiri M, Hatoum S, Buyalos R, Sheidaei A, Azziz R
J Clin Endocrinol Metab
. 2025 Jan;
PMID: 39758024
Background: Polycystic ovary syndrome (PCOS) is a highly prevalent disorder with substantial burden, yet global epidemiological data remains limited. Objectives: To estimate the PCOS prevalence globally. Materials And Methods: We...
3.
Amiri M, Hatoum S, Hopkins D, Buyalos R, Ezeh U, Pace L, et al.
J Clin Endocrinol Metab
. 2024 Jul;
109(10):2640-2657.
PMID: 39078989
Background: Polycystic ovary syndrome (PCOS) is a common female cardiometabolic-reproductive disorder. It is unclear whether the global obesity epidemic is impacting the high PCOS prevalence. Objective: To determine the association...
4.
Ezeh U, Chen Y, Pall M, Buyalos R, Chan J, Pisarska M, et al.
Fertil Steril
. 2024 Feb;
121(6):1040-1052.
PMID: 38307453
Objective: To determine whether alterations in nonesterified fatty acid (NEFA) dynamics or degree of hyperandrogenism (HA) contribute to the difference in insulin sensitivity between women with metabolically healthy obese polycystic...
5.
Yadav S, Delau O, Bonner A, Markovic D, Patterson W, Ottey S, et al.
Elife
. 2023 Aug;
12.
PMID: 37534878
Background: Polycystic ovary syndrome (PCOS) is the most common hormone disorder affecting about one in seven reproductive-aged women worldwide and approximately 6 million women in the United States (U.S.). PCOS...
6.
Riestenberg C, Jagasia A, Markovic D, Buyalos R, Azziz R
J Clin Endocrinol Metab
. 2021 Sep;
107(2):575-585.
PMID: 34546364
Context: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder of reproductive-aged women, affecting approximately 5% to 20% of women of reproductive age. The economic burden of PCOS was...
7.
Hoyos L, Cheng C, Brennan K, Hubert G, Wang B, Buyalos R, et al.
J Assist Reprod Genet
. 2020 Jan;
37(3):589-594.
PMID: 31955339
Purpose: To examine cycle blastocyst euploid rates among age subgroups of oocyte donors. Methods: Retrospective cohort analysis of ova donation in vitro fertilization cycles (OD-IVF) for which trophectoderm biopsy for...
8.
Gass M, Rebar R, Cuffie-Jackson C, Cedars M, Lobo R, Shoupe D, et al.
Maturitas
. 2004 Oct;
49(2):140-7.
PMID: 15474758
Objective: To assess the efficacy and safety of 17-beta estradiol buccal tablets in reducing hot flush frequency (HFF) in postmenopausal women. Methods: Estradiol buccal tablets containing 0.05, 0.1, 0.2, or...